As with numerous scientific disciplines, Computer-Aided Drug Design (CADD) is facing great opportunities and challenges as a consequence of advances in computation and information technology. The 2021 CADD Gordon Conference will shed light on novel computational approaches tightly coupled to modern experimental techniques and applied to practical drug design endeavors.
While small molecule design is still the driving force of CADD, new modalities appear, emphasizing the need for precise chemical models and algorithms resulting in highly efficient computational tools. The conference will present a balanced view on CADD as a research field, focusing on computational methods and their applications. Areas covered include, among others, the modeling of biotherapeutics and large multi-protein complexes, handling of extended, synthetically accessible chemical space and ADMET models beyond statistical learning. Novel experimental techniques such as cryoEM and serial crystallography, DNA-encoded libraries and automated organic synthesis and their consequences for CADD will be discussed. At the same time, advances in computational techniques like machine learning and data science offer new opportunities to transfer data into knowledge. The impact of these technologies to drug design will become a second focal point in the conference.
In the tradition of the GRC, the conference will bring world-leading scientists from academia and industry together in a relaxed atmosphere enabling intense scientific exchange. Junior researchers will participate in the program in the form of selected talks from the preceding GRS, short poster talks and poster presentations. All scientific presentations will have elements of unpublished work. We are looking forward to another outstanding, thought-stimulating GRC CADD conference in 2021.
The conference will consist of nine sessions, on the topics listed below. The conference chair is currently developing their preliminary program, which will include the names of the invited speakers and discussion leaders for each of these sessions. Please check back regularly for updates to this information.
- Keynote Session: Open Challenges in CADD: A Vision for the Next Decade
- Keynote Session: CADD Contributions to Covid-19 Research
- Computational Exploration of New Modalities
- Modeling of Chemical Reactions on a Large Scale
- Next-Generation Machine Learning in Drug Discovery
- Computational Molecular Design in Pharmaceutical Research
- Protein Structures, Dynamics and Design
- Navigating Chemical Space
- ADMET Modeling Beyond QSAR